-
21.
公开(公告)号:DK2635693T3
公开(公告)日:2020-12-21
申请号:DK11838917
申请日:2011-11-04
Applicant: ACADEMIA SINICA
Inventor: TSENG YUNG-CHIEH , WONG CHI-HUEY , MA CHE
IPC: C12P21/06 , A61K39/145 , C12N7/00 , C12N15/09 , C12P21/00
-
公开(公告)号:AU2014317889B2
公开(公告)日:2020-03-05
申请号:AU2014317889
申请日:2014-09-08
Applicant: ACADEMIA SINICA
Inventor: WONG CHI-HUEY , YU ALICE L , LIN KUN-HSIEN , WU TAI-NA
IPC: A61K35/14 , A61K31/7012 , A61K31/739
Abstract: Glycosphingolipids (GSLs) bearing α-glucose (α-Glc) that preferentially stimulate human invariant NKT (iNKT) cells are provided. GSLs with α-glucose (α-Glc) that exhibit stronger induction in humans (but weaker in mice) of cytokines and chemokines and expansion and/or activation of immune cells than those with α-galactose (α-Gal) are disclosed. GSLs bearing α-glucose (α-Glc) and derivatives of α-Glc with F at the 4 and/or 6 positions are provided. Methods for iNKT-independent induction of chemokines by the GSL with α-Glc and derivatives thereof are disclosed. Methods for immune stimulation in humans using GSLs with α-Glc and derivatives thereof are provided.
-
公开(公告)号:HK1254774A1
公开(公告)日:2019-07-26
申请号:HK18113820
申请日:2018-10-30
Applicant: ACADEMIA SINICA
Inventor: WONG CHI-HUEY , WU CHUNG-YI , TSAI TSUNG-I
IPC: C12M20060101
-
公开(公告)号:AU2019203313A1
公开(公告)日:2019-05-30
申请号:AU2019203313
申请日:2019-05-10
Applicant: ACADEMIA SINICA
Inventor: WONG CHI-HUEY , WU CHUNG-YI , TSAI TSUNG-I
Abstract: Abstract A novel UDP-Gal regeneration process and its combined use with a galactosyltransferease to add galactose to a suitable acceptor substrate. Also described herein are synthetic methods for generating Globo-series oligosaccharides in large scale, wherein the methods may involve the combination of a glycosyltransferase reaction and a nucleotide sugar regeneration process.
-
公开(公告)号:CA3034876A1
公开(公告)日:2018-03-01
申请号:CA3034876
申请日:2017-08-23
Applicant: CHO PHARMA INC , ACADEMIA SINICA , LIN NAN HORNG
Inventor: LIN NAN-HORNG , HUANG LIN-YA , SHIVATARE SACHIN , CHEN LI-TZU , WONG CHI-HUEY , WU CHUNG-YI , CHENG TING
Abstract: A mutant of EndoS2 includes one or more mutations in the sequence of a wild-type EndoS2 (SEQ ID NO: 1), wherein the one or more mutations are in a peptide region located within residues 133-143, residues 177-182, residues 184-189, residues 221-231, and/or residues 227-237, wherein the mutant of EndoS2 has a low hydrolyzing activity and a high tranglycosylation activity, as compared to those of the wild-type EndoS2. A method for preparing an engineered glycoprotein using the mutant of EndoS2 includes coupling an activated oligosaccharide to a glycoprotein acceptor. The activated oligosaccharide is a glycan oxazoline.
-
公开(公告)号:AU2018200094A1
公开(公告)日:2018-01-25
申请号:AU2018200094
申请日:2018-01-05
Applicant: ACADEMIA SINICA
Inventor: WONG CHI-HUEY , WU CHUNG-YI , TSAI TSUNG-I
Abstract: Abstract A novel UDP-Gal regeneration process and its combined use with a galactosyltransferease to add galactose to a suitable acceptor substrate. Also described herein are synthetic methods for generating Globo-series oligosaccharides in large scale, wherein the methods may involve the combination of a glycosyltransferase reaction and a nucleotide sugar regeneration process.
-
公开(公告)号:AU2016209056A1
公开(公告)日:2017-07-20
申请号:AU2016209056
申请日:2016-01-25
Applicant: ACADEMIA SINICA
Inventor: WONG CHI-HUEY , WU CHUNG-YI , CHEUNG SARAH K C , CHUANG PO-KAI , HSU TSUI-LING
IPC: G01N33/574 , A61K39/00 , A61P35/00
Abstract: The present disclosure relates to methods and compositions which can modulate the globoseries glycosphingolipid synthesis. Particularly, the present disclosure is directed to glycoenzyme inhibitor compound and compositions and methods of use thereof that can modulate the synthesis of globoseries glycosphingolipid SSEA-3/SSEA-4/GloboH in the biosynthetic pathway; particularly, the glycoenzyme inhibitors target the alpha-4GalT; beta- 4GalNAcT-I; or beta-3GalT-V enzymes in the globoseries synthetic pathway. Additionally, the present disclosure is also directed to vaccines, antibodies, and/or immunogenic conjugate compositions targeting the SSEA-3/SSEA-4/GLOBO H associated epitopes (natural and modified) which elicit antibodies and/or binding fragment production useful for modulating the globoseries glycosphingolipid synthesis. Moreover, the present disclosure is also directed to the method of using the compositions described herein for the treatment or detection of hyperproliferative diseases and/or conditions. Furthermore, the instant disclosure also relates to cancer stem cell biomarkers for disgnostic and therapeutic uses.
-
公开(公告)号:AU2015315294A1
公开(公告)日:2017-04-06
申请号:AU2015315294
申请日:2015-09-08
Applicant: ACADEMIA SINICA
Inventor: YU ALICE L , LIN KUN-HSIEN , WU TAI-NA , WONG CHI-HUEY
Abstract: Glycosphingolipids (GSLs) compositions and methods for iNKT-independent induction of chemokines are disclosed.
-
公开(公告)号:AU2015267051A1
公开(公告)日:2017-01-12
申请号:AU2015267051
申请日:2015-05-27
Applicant: ACADEMIA SINICA
Inventor: WONG CHI-HUEY , TSAI TSUNG-I
IPC: C12N9/24
Abstract: The present disclosure relates to an a-fucosidase having a-(1,2), a-(1,3), a-(1,4), and a-(1,6) fucosidase activity. The present disclosure also relates to the compositions comprising the α-fucosidase, and the methods of producing and using the α-fucosidase in cleaving a-(1,2), a-(1,3), a-(1,4), and/or a-(1,6)-linked fucoses in the glycoconjugates. Accordingly, the present invention provides the compositions and methods for the improved enzymatic hydrolysis of fucose in vitro. In particular, the present invention is useful for the efficient cleavage of core fucose in native glycoproteins without denaturation or functional deterioration of glycoproteins. The compositions and methods of the invention can facilitate the Fc glycoengineering of Fc fusion proteins or antibodies, such as therapeutic antibodies.
-
公开(公告)号:CA2960712A1
公开(公告)日:2016-03-17
申请号:CA2960712
申请日:2015-09-08
Applicant: ACADEMIA SINICA
Inventor: WONG CHI-HUEY , YU ALICE L , LIN KUN-HSIEN , WU TAI-NA
Abstract: Glycosphingolipids (GSLs) compositions and methods for iNKT-independent induction of chemokines are disclosed.
-
-
-
-
-
-
-
-
-